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OXIDASE ACTIVITY OF POLYMERIC 
COATED CERIUM OXIDE NANOPARTICLES 
RELATED APPLICATIONS 
This invention claims the benefit of priority from U.S. 
Provisional Patent Application Ser. No. 61/160,744 filed on 
Mar. 17, 2009 which is incorporated herein by reference. 
2 
2308-2312 (DOI: I0.1002/ANIE.200805279) and was sub-
sequently published on-line Jan. 7, 2009. 
It is desirable to extend the utility of the coated nanoceria 
particles as a stable, effective catalyst and oxidant replacing 
less desirable oxidants, such as, hydrogen peroxide, that are 
chemically unstable and harmful to biological tissue and the 
environment. The present invention provides a much needed 
solution to problems in the prior art. 
SUMMARY OF THE INVENTION 
This invention was made with Govermnent support under 
Agency contract number KOi CAI 01781 awarded by the 10 
National Institutes of Health. The govermnent has certain 
rights in this invention. A primary objective of the present invention is to provide a 
plurality of coated cerium oxide (ceria) nanoparticles that 
behave as oxidants in acidic to moderately alkaline conditions 
15 wherein the pH value is between I and 8. 
FIELD OF THE INVENTION 
This invention relates to uses of nanoceria particles, and in 
particular to methods, systems and compositions useful in the 
synthesis of polymer coated cerium oxide nanoparticles as an 
oxidizing agent and in catalytic applications. 
BACKGROUND AND PRIOR ART 
Unique catalytic activities have been reported in nano scale 
materials in recent years, as described by D. Astruc, et al. in 
Angew Chem Int Ed Engl 2005, 44, 7852. The nanoscale or 
size-dependent properties are often absent in bulk materials 
and are the basis for designing novel catalysts with multiple 
applications in energy storage, chemical synthesis and bio-
medical applications. Cerium oxide has been used exten-
sively in catalytic converters for automobile exhaust systems, 
as an ultraviolet absorber and as an electrolyte for fuel cells. 
Most recently, it has been found that nanosized cerium 
oxide (nanoceria) possesses antioxidant activity at physi-
ological pH and their potential use in biomedical applications 
such as protection against radiation damage, oxidative stress 
and inflanmiation has been reported by various researchers, 
such as, R. W. Tamuzzer, et al. in Nano Lett 2005, 5, 2573; J. 
P. Chen, eta!. in Nature Nanotechnology 2006, I, 142; J. Niu, 
et al in Cardiovasc Res 2007, 73, 549; M. Das, et al. in 
Biomaterials 2007, 28, 1918 and J.M. Perez, et al. in Small 
2008, 5, 552-556. 
The ability of these nanoparticles to act as an antioxidant 
resides in their ability to reversibly switch from Ce+3 to Ce+4 
20 
A secondary objective of the present invention is to provide 
coated cerium oxide (ceria) nanoparticles with the ability to 
oxidize organic substrates without the need of hydrogen per-
oxide. 
A third objective of the present invention is to provide 
coated cerium oxide (ceria) nanoparticles that are excellent 
aqueous phase redox catalyst. 
A fourth objective of the present invention is to provide 
coated cerium oxide (ceria) nanoparticles to decompose or 
25 inactivate via oxidation processes, toxins, toxic organic com-
pounds, such as phenols, and pesticides in wastewater treat-
ment and toxic chemical agents, such as nerve agents. 
A fifth objective of the present invention is to provide 
coated cerium oxide (ceria) nanoparticles that function as 
30 nanocatalyst in immunoassays, such as ELISA, where horse-
radish peroxidase labeled secondary antibodies are needed to 
facilitate the oxidation and color development of the dye. 
A sixth objective of the present invention is to provide a 
water stable, biodegradable polyacrylic acid coated nanoceria 
35 particle wherein a small molecule can be conjugated to the 
polyacrylic acid coating of the nanoceria particle and used in 
nanoceria-based immunoassays that do not require hydrogen 
peroxide. 
A seventh objective of the present invention is to provide 
40 coated nanoceria particles having dual functionality of bind-
ing and detection and useful as a detection tool. 
An eighth objective of the present invention is to provide a 
coated cerium oxide ( ceria) nanoparticle based immunoassay 
method that is easier, faster, more economical and provides 
45 greater sensitivity. 
as reported by M. Das, et al. inBiomaterials 2007, 28, 1918. 
Furthermore, the synthesis of a biocompatible dextran-coated 
nanoceria (DNC) preparation and enhanced stability in aque-
ous solution has been recently reported in co-pending U.S. 
patent application Ser. No. 11/965,343 filed on Dec. 27, 2007, 
the content of which is incorporated herein by reference; it 
was also reported that the polymeric coating does not affect 50 
the autocatalytic properties of nanoceria, as hydrogen perox-
ide and peroxyl radicals can diffuse through the hydrophilic 
polymer coating and oxidize Ce+3 to Ce+4 . Thus, coatednano-
ceria particles are used as antioxidants in biomedical appli-
cations, such as, protection against radiation damage, oxida-
tive stress and inflammation. 
A ninth objective of the present invention is to provide 
coated ceria nanoparticles formed step-wise for use in 
improved therapeutic agents, cyto-protecting devices and 
detecting devices. 
A preferred in situ method for the synthesis of a plurality of 
cerium oxide nanoparticles coated with a biodegradable poly-
mer for antioxidant, free-radical scavenging and autocatalytic 
biomedical applications is also useful in the present inven-
tion, and is previously disclosed in commonly-assigned, co-
55 pending U.S. patent application Ser. No. 12/169,179. 
Further objects and advantages of the present invention 
will be apparent from the following detailed description of a 
presently preferred embodiment which is illustrated sche-
matically in the accompanying drawings. 
In co-pending U.S. patent application Ser. No. 12/169, 179, 
the content of which is incorporated herein by reference; it is 
reported that in-situ synthesized coated nanoceria particles 
with enhanced biocompatibility and stability in aqueous solu- 60 
tion exhibit a pH-dependent antioxidant activity and provide 
a means for tailoring reversible and non-reversible antioxi-
dant properties of coated nanoceria particles. 
A journal article by Atul Asati, Santimukul Santra, 
Charalambos Kaittanis, Sudip Nath, J. Manuel Perez, 65 
entitled, "OxidaseActivity of Polymer-Coated Cerium Oxide 
Nanoparticles" published inAngew. Chem. Int. Ed. 2008, 47, 
BRIEF DESCRIPTION OF THE FIGURES 
FIG. lA is a Fourier Transform Infrared (FT-IR) spectra 
showing the presence of characteristic infrared (IR) bands of 
both polyacrylic acid (PAA) and PAA coated nanoceria 
(PNC) confirming that the polymer coating is an integral part 
of nanoceria. 
US 8,883,519 Bl 
3 
FIG. lB is a Fourier Transform Infrared (FT-IR) spectra 
showing the presence of characteristic infrared (IR) bands of 
both dextran polymer and dextran coated nanoceria (DNC) 
confirming that the dextran coating is an integral part of 
nanocena. 
FIG. 2 shows separate vials of dextran coated nanoceria 
(DNC)-catalyzed oxidation of3 ,3 ', 5, 5'-tetramethy 1 benzidine 
(TMB), in the absence of hydrogen peroxide, at pH 4.0 yield-
ing a blue color and dextran coated nanoceria (DNC)-cata-
lyzed oxidation of 2,2-azinobis-(3-ethylbenzothizoline-6-
sulfonic acid) (AzBTS), in the absence ofhydrogen peroxide, 
at pH 4.0 yielding a green color. 
FIG. 3A is a graph of the UV visible spectrum exhibited 
during polymer coated nanoceria mediated oxidation of3,3', 
5,5'-tetramethyl benzidine (TMB) to a blue cation radical 
with characteristic peaks at 370 nm wavelength and 652 nm 
wavelength. The peak at 370 nm corresponds to the yellow 
color state which remains for only a few seconds. 
4 
and step-wise DNC (100 nm), showing that the small size 
ceria nanoparticles show higher oxidase activity than large 
size nanoparticles. 
FIG. llA is a double reciprocal plot of oxidase activity of 
polymer coated nanoceria at pH 4.0 using 3,3',5,5'-tetram-
ethyl benzidine (TMB) as substrate providing a steady state 
kinetic assay. 
FIG. llB is a double reciprocal plot of oxidase activity of 
polymer coated nanoceria at pH 5.0 using 3,3',5,5'-tetram-
10 ethyl benzidine (TMB) as substrate providing a steady state 
kinetic assay. 
FIG. llC is a double reciprocal plot of oxidase activity of 
polymer coated nanoceria at pH 6.0 using 3,3',5,5'-tetram-
ethyl benzidine (TMB) as substrate providing a steady state 
15 kinetic assay. 
FIG. 3B is a graph of the UV visible spectrum exhibited 
during polymer coated nanoceria mediated oxidation of 2,2- 20 
azinobis-(3-ethylbenzothizoline-6-sulfonic acid) (AzBTS), 
FIG. llD is a double reciprocal plot of oxidase activity of 
polymer coated nanoceria at pH 7.0 using 3,3',5,5'-tetram-
ethyl benzidine (TMB) as substrate providing a steady state 
kinetic assay. 
FIG. 12A is a double reciprocal plot of oxidase activity of 
in-situ synthesized polyacrylic acid coated nanoceria (PNC) 
at pH 4.0 using 3,3',5,5'-tetramethyl benzidine (TMB) as 
substrate providing a steady state kinetic assay. 
to a green cation radical with characteristic peak at 475 mu 
wavelength. 
FIG. 4 shows the absence of color development indicating 
no significant oxidation ofTMB or AxBTS at pH 7 .0 after the 
addition of polymer coated nanoceria, even in the presence of 
hydrogen peroxide and overnight incubation. 
FIG. 5 shows DNC-catalyzed oxidation of3,3',5,5'-tetram-
ethyl benzidine (TMB), in the absence of hydrogen peroxide, 
at pH 4.0, pH, 5.0, pH 6.0 and pH 7.0. 
FIG. 6 is a drawing of vials of polymer coated nanoceria 
catalyzed oxidation of Dopamine (DOPA) to an orange color 
aminochrome in citrate buffer at pH 4.0. 
FIG. 7 is a graph of UV visible spectrum exhibited during 
polymer coated nanoceria mediated oxidation of DOPA to 
orange aminochrome with a characteristic band at 475 nm 
wavelength. 
FIG. SA shows the average hydrodynamic diameter distri-
bution of approximately 14 nm for in-situ synthesized dextran 
coated nanoceria of the present invention using dynamic light 
scattering (DLS). 
FIG. SB shows the average hydrodynamic diameter distri-
bution of approximately 100 nm for step-wise synthesized 
dextran coated nanoceria of the present invention using 
dynamic light scattering (DLS). 
FIG. SC shows the average hydrodynamic diameter distri-
bution of approximately 5 nm for in-situ synthesized poly-
acrylic acid (PAA) coated nanoceria of the present invention 
using dynamic light scattering (DLS). 
FIG. SD shows the average hydrodynamic diameter distri-
bution of approximately 12 nm for step-wise synthesized 
polyacrylic acid (PAA) coatednanoceria of the present inven-
tion using dynamic light scattering (DLS). 
FIG. 12B is a double reciprocal plot of oxidase activity of 
25 step-wise synthesized polyacrylic acid coated nanoceria 
(PNC) at pH 4.0 using 3,3',5,5'-tetramethyl benzidine (TMB) 
as substrate providing a steady state kinetic assay. 
FIG. 12C is a double reciprocal plot of oxidase activity of 
in-situ synthesized dextran coated nanoceria (DNC) at pH 4.0 
30 using 3,3',5,5'-tetramethyl benzidine (TMB) as substrate pro-
viding a steady state kinetic assay. 
FIG. 12D is a double reciprocal plot of oxidase activity of 
step-wise synthesized dextran coated nanoceria (DNC) at pH 
4.0 using 3,3',5,5'-tetramethyl benzidine (TMB) as substrate 
35 providing a steady state kinetic assay. 
FIG. 13 is a schematic design of traditional Enzyme-
Linked ImmunoSorbent Assay (ELISA) with a horseradish 
peroxidase (HRP) labeled secondary antibody treated with 
hydrogen peroxide to facilitate oxidation of3,3',5,5'-tetram-
40 ethyl benzidine (TMB) resulting in color development 
(PRIOR ART) 
FIG. 14 is a schematic design of a polymer coated nanoc-
eria-based ELISA showing the direct oxidation of 3,3',5,5'-
tetramethyl benzidine (TMB) without the use of HRP or 
45 hydrogen peroxide. 
FIG. 15 is a schematic depiction of the synthesis offolate-
conjugated nanoceria particles via click chemistry wherein 
folic acid is used in carbodiimide chemistry to create folate 
compound that is conjugated to polyacrylic acid (PAA) 
50 coated nanoceria. 
FIG. 9 is a graph of coated nanoceria's ability to oxidize 
3,3',5,5'-tetramethyl benzidine (TMB), with the following 55 
nanoparticle sizes in-situ PNC (5 nm), step-wise PNC (12 
nm), in-situ DNC (14 nm) and step-wise DNC (100 nm), 
showing that the small size ceria nanoparticles show higher 
oxidase activity than large size nanoparticles. 
FIG. 16 is the fluorescence profile of folate-conjugated 
nanoceria particles showing a peak for ceria at 410 nm wave-
length and a peak for folate at 450 nm wavelength confirming 
conjugation was successful using click chemistry. 
FIG. 17 is a graph of product formation when increasing 
concentrations (from 0.5 µM -5.0 µM) of folate-conjugated 
polymer coated nanocaria are incubated separately with lung 
carcinoma cells (A-549) and cardiac myocytes (H9c2) for 
three hours followed by incubation with 3,3',5,5'-tetramethyl 
FIG. lOA is a graph of polymer coated nanoceria's ability 
to oxidize 2,2-azinobis-(3-ethylbenzothizoline-6-sulfonic 
acid) (AzBTS) at pH4.0, pH 5.0, pH 6.0 and pH 7 .0 at room 
temperature for a period of approximately ten minutes. 
FIG. lOB is a graph of polymer coated nanoceria's ability 
to oxidize 2,2-azinobis-(3-ethylbenzothizoline-6-sulfonic 
acid) (AzBTS) with the following nanoparticle sizes in-situ 
PNC (5 nm), step-wise PNC (12 nm), in-situ DNC (14 nm) 
60 benzidine (TMB) for 30 minutes at 652 nm wavelength. 
FIG. lS is a graph showing results when a constant amount 
(5.0 µM) of folate-conjugated polymer coated nanoceria is 
exposed to an increasing number (from 1500 to 6000) of 
folate-positive lung carcinoma cells (A549), the ability of 
65 folate-conjugated nanoceria to identify the target carcinoma 
cells increased as the number of folate receptors increased on 
lung carcinoma cells. 
US 8,883,519 Bl 
5 
FIG. 19A is a schematic diagram showing the in-situ syn-
thesis of coated nanoceria. In this example, the molecular 
weight of polyacrylic acid is 1,000 and the molecular weight 
of dextran is 10,000; a small diameter (3 nm) ceria nanopar-
ticle is coated with a thick polymer coating in the in-situ 
process. 
FIG. 19B is a schematic diagram showing the step-wise 
synthesis of coated nanoceria. In this example, the molecular 
weight of polyacrylic acid is 1,000 and the molecular weight 
of dextran is 10,000; a large diameter (7 nm) ceria nanopar-
ticle is coated with a thick polymer in the step-wise process. 
6 
FIG. 27A is a graph of the absorbance of a fluorescent 
chromogenic substrate to detect MCF-7 breast carcinoma 
cells at pH 7 .0 
FIG. 27B is a graph of the absorbance of chromogenic 
substrate to detect MCF-7 breast carcinoma cells at pH 4.0 
FIG. 28A is a schematic drawing of nanoceria mediated 
oxidation of Ampliflu to produce a stable fluorescent product 
FIG. 28B is a schematic drawing of traditional, state-of-
the-art horseradish peroxidase/hydrogen peroxide (HRP/ 
10 H2 0 2 ) mediated oxidation of Ampliflu that produces an un-
stable fluorescent product that becomes a non-fluorescent 
final product. (PRIOR ART) FIG. 20A is a drawing of vials containing polymeric 
cerium oxide nanoparticles used in the oxidation of colori-
metric/fluorimetric dye substrates, Ampliflu and OPD, at pH 15 
7.0. 
DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
FIG. 20B is a drawing of vials containing polymeric 
cerium oxide nanoparticles used in the oxidation of colori-
metric/fluorimetric dye substrates, Ampliflu and OPD at pH 
4.0. 
FIG. 20C is a drawing of an ultraviolet (UV) image of vials 
containing polymeric cerium oxide nanoparticles used in the 
oxidation of colorimetric/fluorimetric dye substrates, 
Ampliflu and OPD, at pH 7.0. 
FIG. 20D is a drawing ofan ultraviolet (UV) image of vials 
containing polymeric cerium oxide nanoparticles used in the 
oxidation of colorimetric/fluorimetric dye substrates, 
Ampliflu and OPD, at pH 4.0. 
FIG. 21A is a graph of the UV spectrum for oxidized 
Ampliflu showing the absorbance maximum at 565 nm wave-
length. 
FIG. 21B is a graph of the fluorescence spectrum of oxi-
dized Ampliflu showing an emission peak at 585 nm wave-
length. 
FIG. 21C is a graph of UV spectrum for oxidized o-phe-
nylene diamine showing the absorbance maximum at 417 nm 
wavelength. 
FIG. 21D is a graph of the fluorescence spectrum of oxi-
dized o-phenylene diamine showing an emission peak at 570 
nm wavelength. 
FIG. 22 is a schematic representation of the conjugation of 
Protein-G on polyacrylic acid coated cerium oxide nanopar-
ticles. 
Before explaining the disclosed embodiments of the 
present invention in detail it is to be understood that the 
20 invention is not limited in its application to the details of the 
particular arrangements shown since the invention is capable 
of other embodiments. Also, the terminology used herein is 
for the purpose of description and not of limitation. 
Ampliflu is the common chemical name for (10-acetyl-3, 
25 7-dihydroxy-phenoxazine), a chromogenic fluorescent dye. 
AzBTS is the chemical abbreviation for 2,2-azinobis-(3-
ethylbenzothizoline-6-sulfonic acid) 
The term "chromogenic" is used to refer to compound that 
contains a chromophore and is capable of becoming a dye it is 
30 used herein in combination with the term "colorimetric" 
The term "colorimetric" is used to refer to a dye compound 
that is useful in chemical analysis wherein there is a compari-
son of a liquid's color with standard colors. 
DNC is the acronym used herein to mean dextran coated 
35 nanoceria. Dextran is a complex, branched polysaccharide 
made of many glucose molecules. 
The term "fluorescent" is used to refer to a dye compound 
that is useful in a fluorimetric analytical process wherein 
measurements of fluorescence and related phenomena, such 
40 as intensity or radiation are observed; the observation of 
fluorescence is commonly described as bright and glowing. 
OPD is the chemical abbreviation for ortho-phenylene 
diamine, a chromogenic fluorescent dye. 
FIG. 23 is a graph confirming the protein-G conjugation to 45 
polyacry lie acid coated (P AA-Ceria) nanoceria by zeta poten-
tial measurement. 
PAA is the acronym used herein to mean polyacrylic acid. 
PNC is the acronym used herein to mean polyacrylic acid 
coated nanoceria. 
TMB is the chemical abbreviation for 3,3',5,5'-tetramethyl 
benzidine. FIG. 24A is a schematic drawing showing nanoceria-Pro-
tein-G-antibody based cellular ELISA. 
FIG. 24B is a schematic drawing showing traditional state- 50 
of-the-art horseradish peroxidase/hydrogen peroxide (HRP/ 
H2 0 2 ) antibody based ELISA. (PRIOR ART) 
The term "biocompatible polymer" is used herein to 
describe a class of polymers that are non-toxic to mammals 
and the environment and more specifically, include dextran, 
derivatives of dextran such as reduced dextran, carboxylm-
ethyl reduced dextran, a polyol polymer or carbohydtrate 
polymer, synthetic polyols, carboxylated polymers, such as 
FIG. 25A is a graph of the fluorescence intensity when 
monitoring the expression of folate receptor on folate positive 
lung carcinoma cell line. 
FIG. 25B is a graph of the fluorescence intensity when 
monitoring the expression of MCF-7 breast carcinoma cell 
lines which do not express the folate receptor; this graph is 
used as a control. 
55 polyacrylic acid, and other polysaccharides, such as, but not 
limited to, arabinogalactan, and chitosan as disclosed in Gro-
man et al. U.S. Patent Publication 2006/0014938 and Gaw et 
al. U.S. Patent Publication 2003/0124,194. 
FIG. 26A is a graph showing the expression of Epithelial 60 
Cell Adhesion Molecule (Epi-CAM) on MCF-7 breast carci-
noma cell lines using nanoceria-Protein-G-conjugated with 
an anti-Epi-CAM antibody-conjugate. 
FIG. 26B is a graph showing the screening of Epi-CAM 
receptor on MCF-7 breast carcinoma cell lines using the 65 
traditional horseradish peroxidase/hydrogen peroxide (HRP/ 
H2 0 2 ) system. 
The term "click chemistry" used herein, is a chemical 
philosophy introduced by K. Barry Sharpless of Scripps 
Research Institute in 2001 and describes chemistry tailored to 
generate substances quickly and reliably by joining small 
units together under simple reaction conditions resulting in 
high chemical yield. 
The term "coated nanoceria" is used herein to refer to 
cerium oxide nanoparticles coated with any bio-compatible 
polymer useful in the present invention. For purposes of illus-
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tration, but not as a limitation, the two polymeric coatings 
discussed in the examples are polyacrylic acid and dextran (a 
polysaccharide ). 
8 
would result in a better control of the catalytic activity or 
oxidase at acidic pH and antioxidant activity at neutral pH of 
the coated nanoceria. Similar tunability of the oxidase activ-
ity occurs with in-situ synthesized biodegradable polymer 
coated ceria nanoparticles when a large molecular weight 
polymer is used to coat the ceria nanoparticle; the larger the 
molecular weight, the slower the rate of oxidase activity. 
The examples below provide further detail on the synthesis 
and physical characterization of the biodegradable polymer 
"ELISA" is the acronym for Enzyme-Linked ImmunoSor-
bentAssay which is a biochemical technique used to evaluate 
either the presence of antigen or the presence of antibody, 
such as with the HIV test or West Nile Virus. ELISA is a 
diagnostic tool in medicine and plant pathology, as well as a 
quality control check in various industries. For example, in 
the food industry, ELISA is used to detect food allergens such 
as milk, peanuts, walnuts, almonds, and eggs. 
The term "nanoceria" is used interchangeably with 
"cerium oxide nanoparticles" and is used to refer to the 
cerium oxide particles of multiple valences. 
10 coated ceria nanoparticles of the present invention. Poly-
acrylic acid (PAA) and dextran, a polysaccharide, are used as 
exemplary polymeric coatings and are not a limitation of the 
present invention; other bio-compatible polymers may be 
judicially selected by a person of skill in the art. Also, in the 
The term "nanocrystal" is used interchangeably with 
"nanoparticle." 
In the present invention, the cerium oxide nanoparticles or 
nanoceria are polymer associated, or, in other words, coated 
with a bio-compatible polymer. The polymer confers stability 
in water and can be functionalized with carboxylic or amino 
groups for conjugation with proteins, peptides, oligonucle-
otides, small molecules, and the like. 
15 examples below, the sensitive colorimetric/chromogenic 
organic dyes chosen are 3,3',5,5'-tetramethyl benzidine 
(TMB) and 2,2-azinobis-(3-ethylbenzothizoline-6-sulfonic 
acid) (AzBTS); however, it is understood that these chro-
mogenic dyes for horseradish peroxidase (HRP) are only 
Further, as will be explained in detail, the oxidant activity 
of the coated nanoceria particles is facilitated in an acidic pH, 
from approximately 1 to approximately 4 when a colorimet-
ric/chromogenic dye is used as the substrate; whereas, in an 
acidic to moderately alkaline pH, from approximately 4.0 to 
approximately 8.0, oxidant activity of the coated nanoceria 
particles is facilitated when a colorimetric/chromogenic/ 
fluorescent dye is used as the substrate. In a pH range from 
approximately 8 to approximately 11, the coated nanoceria 
particle does not function as an oxidant, unless there are 
changes made to the dye substrate, thus permitting the design 
20 representative of dyes used in detection and analysis meth-
ods. Other chromogenic substrates for HRP can be used; 
other sensitive dyes can be used and include, but are not 
limited to chromogenic, fluorescent, photoluminescent sub-
strates of a peroxidase or an oxidase. It has been determined 
25 that sensitive dyes that combine the chromogenic and fluo-
rescent properties extend oxidant activity of nanoceria par-
ticles in the pH range from acidic to moderately alkaline, i.e., 
pH 4 to pH 8. The extended pH range of oxidase activity is 
important for use on substrates that are unstable in low pH 
30 conditions, such as pH values of 1 to 4. 
Herein, coated nanoceria is reported to have an intrinsic 
oxidase activity at acidic pH. Since nanoceria possess a 
higher ratio ofCe+4 to Ce+3 at pH 4, it is found to behave as an 
oxidant in slightly acidic conditions. In fact, nanoceria of improved catalysts, oxidizing agents and detection 
devices. 35 behaves as an oxidant at pH 4 as it can quickly oxidize a series 
of organic substrates without an oxidizing agent, such as, 
hydrogen peroxide. The observed activity is not only pH-
dependent, but also dependent on the size of the cerium oxide 
In general, the plurality of coated nanoceria particles of the 
present invention each have a size between approximately 1 
nanometer (nm) to approximately 500 nm in diameter, pref-
erably between approximately 7 nm and approximately 100 
nm. For example, the coated nanoceria particles used herein 40 
are composed of a cerium oxide core that is approximately 4 
nanometers (nm) in diameter surrounded by a dextran coating 
for a total nanoparticle size of approximately 10 nm in diam-
eter, as disclosed in U.S. patent application Ser. No. 12/169, 
179, which is incorporated herein by reference. 
nanoparticles, as well as the thickness of the polymer coating. 
Based on the above findings, an immunoassay is designed 
in which a folate-conjugated cerium oxide nanoparticle pro-
vides dual functionality ofbinding to folate expressing cancer 
cells and detection via catalytic oxidation of sensitive colori-
metric substrates/dyes. The unique pH-dependent oxidase 
45 activity of coated cerium oxide nanoparticles in aqueous 
media makes them a powerful tool for wide range of potential 
applications in biotechnology and environmental chemistry. 
Briefly, the in-situ synthesis of coated nanoceria in U.S. 
patent application Ser. No. 12/169,179 consists of mixing an 
aqueous solution of cerium nitrate and dextran and adding the 
mixture to an ammonia solution under continuous stirring. 
Upon formation of the cerium oxide nanocrystals, molecules 50 
of dextran coat the nanoparticle surface, preventing further 
growth and resulting in dextran coated nanoceria. 
EXAMPLE 1 
In-Situ Synthesis ofDextran Coated Ceria 
Nanoparticles (DNC) and Polyacrylic Acid-Coated 
Ceria Nanoparticles (PNC) 
Under ambient conditions, a 1 M cerium nitrate (Aldrich, 
99%) solution (2.17 gin 5 ml of water) was mixed with a 
1.0M Dextran T-10 (Sigma) (5 gin 10 ml of water) to form 
mixture (I) comprising a plurality of ceria nanoparticles. 
The present invention provides a step-wise method and 
procedure for synthesizing a biodegradable polymer coated 
ceria nanoparticle having a thicker coating of the ceria nano- 55 
particle than the coating obtained using the in-situ synthesis 
method. The thicker coating allows the oxidase activity to be 
tuned or adjusted because a thicker coating results in a slower 
oxidase activity and a thinner coating allows for faster oxi-
dase activity of the coated ceria nanoparticle. 
Alternately, if preparing polyacrylic acid (PAA) coated 
60 nanoceria, 0.5 M solution of polyacrylic acid (PAA) (Sigma) 
is used instead of 1.0M Dextran T-10 to form mixture (I). Also, the nature and molecular weight of the polymer plays 
a role in the thickness of the coating. In the examples provided 
herein, the molecular weight of polyacrylic acid is approxi-
mately 1,000 and the molecular weight of dextran is approxi-
mately 10,000. Therefore, one would obtain on average a 65 
thicker coating of dextran as opposed to polyacrylic acid. 
Controlling the thickness of the polymer coating on nanoceria 
Under continuous stirring, the mixture (I) is then added 
dropwise to 30 ml of 29% ammonium hydroxide solution 
(Fischer, USA) forming mixture (II). Mixture (II) is then 
stirred continuously for 24 hours. After 24 hours of stirring, 
the solution turns from a light yellow to a deep brown color 
indicating the formation of stabilized dextran or PAA coated-
US 8,883,519 Bl 
9 10 
particles, the solution changes to a green color indicating the 
oxidation of 2,2-azinobis-(3-ethylbenzothizoline-6-sulfonic 
acid). 
Further evidence of the oxidase activity of the dextran-
nanoceria. The preparation is centrifuged at a rate of 4000 
rpm for two 30-minute cycles to settle down any debris and 
large agglomerates. The supernatant solution is then purified 
by removal of free polyacrylic acid (PAA) or dextran by 
ultrafiltration using a 30 KAmicon cell (Millipore Inc.). 
EXAMPLE2 
Step-Wise Synthesis of Dextran Coated Ceria 
Nanoparticles (DNC) and Polyacrylic Acid-Coated 
Ceria Nanoparticles (PNC) 
5 coated nanoparticles (DNC) is shown by the corresponding 
UV-visible spectrum. In FIG. 3A, TMB (3,3',5,5'-tetramethyl 
benzidine) (TMB) is oxidized to form a blue cation radical 
with characteristic peaks at 370 nm and 652 nm wavelength. 
The peak at 370 nm corresponds to the yellow color state 
For stepwise synthesis, a solution containing IM cerium 
(III) nitrate (2.17 g in 5.0 ml of water) was added under 
continuous stirring to 30.0 ml ammonium hydroxide solution. 
Then, after one minute, 0.5 M solution of PAA, if preparing a 
polyacrylic aicd (PAA)-coated ceria nanoparticle (PNC) or 
1.0 M dextran solution, if preparing a dextran coated ceria 
nanoparticle (DNC) is added and allowed to stir for 3 hours. 
Purification and subsequent processing steps are the same as 
in-situ method. A thicker polymer coating results with the 
step-wise preparation that omits the separate steps of forming 
10 which remains for only a few seconds and the peak at 652 nm 
indicates the stable blue color, the change to the blue color 
occurs within two minutes. Moreover, TMB can be com-
pletely oxidized using a higher concentration of nanoceria to 
the corresponding di-imine product which gives a character-
15 istic peak at 450 nm with complete yellow color (not shown). 
The UV-visible spectrum in FIG. 3B for 2,2-azinobis-(3-
ethylbenzothizoline-6-sulfonic acid) (AzBTS) oxidation 
gives a green color radical cation at 475 nm. The entire 
transformation takes place within 2 minutes which explains 
20 the fast kinetic of coated nanoceria mediated oxidation. 
a mixture (I) and adding mixture (I) dropwise to mixture (II). 
For both preparations, the PAA or DNC polymer coating is 25 
confirmed by performing the Fourier Transform Infrared (FT-
IR) analysis on the dry sample of preparations as shown in 
FIG. lA showing the presence of characteristic IR bands of 
both polyacrylic acid (PAA) and PAA coated nanoceria 
(PNC) confirming that the polymer coating is an integral part 30 
of nanoceria particles, since characteristic IR peaks of PAA 
are also present in the PAA-coated nanoceria spectrum and 
FIG. lB showing the presence of characteristic IR bands of 
both dextran alone and dextran coated nanoceria (DNC) con-
firming that the polymer coating is an integral part of nanoc- 35 
eria, since characteristic IR peaks of dextran are also present 
in the dextran-coated nanoceria (DNC) spectrum. 
EXAMPLE3 
Meanwhile, at pH 7 .0, no significant oxidation ofTMB or 
AzBTS is observed, even in the presence of hydrogen perox-
ide or upon overnight incubation, as judged by the absence of 
color development when TMB and AzBTS are added to 
cerium oxide nanoparticles in a citrate buffered solution at a 
neutral pH 7.0 as shown in FIG. 4. The solution remains clear 
or colorless at neutral pH, indicating that no oxidation has 
occurred. 
EXAMPLE4 
Oxidation Properties Decrease with Increase in pH 
Furthermore, pH-dependent studies of the DNC-catalyzed 
oxidation ofTMB show that as the pH of the buffered solution 
increases from pH 4.0 to 7 .0, the ability ofDNC to oxidize the 
dye decreases as shown in FIG. 5. At pH 4.0 the absorbance at 
652 nm for DNC catalyzed oxidation of TMB is approxi-
mately 0.5 after two minutes and remains stable for more than 
Oxidation of Organic Dyes at Low pH 
40 10 minutes. At pH5. 0, absorbance at 65 2 nm is approximately 
0.25 after two minutes and remains stable for more than 10 
In a first set of experiments, a DNC preparation discussed 
by J.M. Perez et al. in Small 2008, 4, No. 5, 552-556 is used 
minutes. At pH 6.0, absorbance is approximately 0.2 after two 
minutes and remains stable for more than 10 minutes. At pH 
7 .0, absorbance is approximately 0.1 after 2 minutes and 
to facilitate the oxidation of a series of organic dyes at low pH. 45 remains stable for more than 10 minutes-at this absorbance 
In these experiments, 3,3',5,5'-tetramethyl benzidine (TMB) 
and 2,2-azinobis-(3-ethylbenzothizoline-6-sulfonic acid) 
(AzBTS), are selected and oxidation develop either a blue 
(TMB) or green (AzBTS) color in aqueous solution. These 
dyes are typically used as horseradish peroxidase (HRP) sub- 50 
strates in various bioassays and most recently they have been 
used to demonstrate the peroxidase activity of iron oxide 
nanoparticles, as reported by L. Z. Gao, et al. in Nature 
Nanotechnology 2007, 2, 577. However, in these peroxidase-
catalyzed reactions, hydrogen peroxide (H20 2 ) is required as 55 
the electron acceptor or oxidizing agent. 
In contrast, it is found that DNC catalyzes the fast oxida-
tion (within minutes) of both TMB andAzBTS in the absence 
of hydrogen peroxide, as judged by the appearance of the 
characteristic color upon addition of the dyes to citrate-buff- 60 
ered solutions of coated ceria nanoparticles at pH 4.0, as 
shown in FIG. 2. In FIG. 2, a citrate-buffered solution of 
coated cerium oxide nanoparticles begins as a solution with a 
clear color and when TMB is added, the solution changes to 
a blue color indicating the oxidation of 3,3',5,5'-tetramethyl 65 
benzidine (TMB). Likewise, when AzBTS is added to the 
clear solution of citrate-buffered coated cerium oxide nano-
level, there is no color change. These results suggest that 
DNC behaves as an oxidizing agent in a pH-dependent man-
ner, being most optimal at acidic pH. 
EXAMPLE 5 
Oxidation of Dopamine (DOPA) 
To further verify the ability of coated nanoceria to behave 
as an oxidationnanocatalyst, dopamine (DOPA), a catechola-
mine difficult to oxidize at low pH was chosen. Results show 
that DNC facilitated the oxidation of DOPA in a citrate buff-
ered solution at pH 4.0 within minutes, producing the char-
acteristic orange color corresponding to aminochrome, one of 
the major oxidation products of DOPA as shown in FIG. 6. 
Dextran coatednanoceria (DNC) in a citrate buffered solution 
at pH 4.0 is a clear, colorless solution and with the addition of 
dopamine (DOPA), within minutes an orange color appears. 
The formation of aminochrome by DNC was confirmed by 
UV-visible light spectrum studies which show the appearance 
of the characteristic band at 475 nm indicating the formation 
ofaminochrome as shown in FIG. 7. In the absence ofDNC, 
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no apparent oxidation of DOPA occurs at pH 4.0, even after 
days of incubation. This is in contrast to DOPA solutions in 
water or citrate buffer pH 7.0, where DOPA slowly auto-
oxidizes, developing the characteristic reddish-brown color 
after overnight incubation (16 hours). Taken together, the 
results demonstrate that DNC can be employed for the oxi-
dation of sensitive dyes and is also able to catalyze the oxi-
dation of various organic molecules at acidic pH, even diffi-
cult to oxidize organic compounds, such as dopamine 
(DOPA). 10 
It has been well established that the catalytic properties of 
nanomaterials often depend upon the size of the nanocrystal, 
as discussed by M. Shokouhimehr, et al. inAngew. Chem. Int. 
Ed Engl. 2007, 46, 7039. However, studies on the effect of 
polymer coating thickness surrounding the nanoparticles are 
15 
less common. In the present invention, a study of coated 
nanoceria-catalyzed oxidation of dyes is undertaken to deter-
mine if oxidation is also size- and polymer-coating-thick-
ness-dependent. Previously reported dextran-coated nanoc- 20 
eria (DNC) preparation was synthesized via an in-situ 
procedure reported by J.M. Perez et al in Small 2008 supra in 
which the dextran (10 kDa) is present in solution at the time 
of the initial formation of the cerium oxide nanocrystals. 
Under these conditions, the polymer influences both the 25 
nucleation and growth of the initial nanocrystal, resulting in 
nanoparticles with a small nanocrystal core surrounded by a 
thin polymeric coating. In the case ofDNC, we have obtained 
nanoparticles with a cerium oxide core of 4 nm surrounded by 
a thin coating of dextran for a total nanoparticle size (hydro- 30 
dynamic diameter) of 14 nm. 
In the present invention, a step-wise procedure for synthe-
sizing coated ceria nanoparticles is used. In a first step, the 
ceria nanoparticles are formed; then, in a second step, the 
polymer is added at a specific time after initial formation of 35 
the nanoparticles. A step-wise method has been previously 
reported for the synthesis of coated iron oxide nanoparticles, 
yielding iron-oxide nanoparticles with a thicker polymer 
coating as compared to an in-situ process according to H. Lee 
et al in Journal of the American Chemical Society 2006, 128, 40 
7383. In addition, slightly larger nanocrystal cores are also 
obtained using this method. 
Therefore, to study the effect of the polymeric coating 
thickness on the catalytic activity of nanoceria, dextran 
coated nanoparticles (DNC) were synthesized using a step- 45 
wise method. In this method the dextran polymer was added 
60 seconds after initial formation of the nanocrystals, to yield 
a step-wise DNC (swDNC) nanoparticle preparation with 
average hydrodynamic diameter of 100 nm, as shown in FIG. 
SB which is approximately 10 times larger than the DNC 50 
nanoparticles obtained with the in-situ method (isDNC), 
shown in FIG. SA with an average hydrodynamic diameter of 
14nm. 
In addition, a coated nanoceria was synthesized using poly-
acrylic acid (1.8 kDa). The use of a smaller molecular weight 55 
polymer in the synthesis of coated nanoceria is advantageous 
because it would allow the formation of nanoparticles with an 
even thinner coating than those obtained with dextran (10 
kDa) using either the in-situ or step-wise method. Dynamic 
light scattering experiments show that for the in situ poly-
acrylic-acid-coatednanoceria preparations (isPNC), the aver-
age hydrodynamic diameter of the nanoparticles was 5 nm, as 
shown in FIG. SC. Meanwhile, for the stepwise preparation 
60 
( sw PNC), a value ofl 2 nm was obtained as shown in FIG. SD. 
As hypothesized, smaller nanoparticles with a thinner 65 
polymer coating were obtained using the 1.8 kDa polyacrylic 
acid polymer. It is also possible to prepare thicker polymer 
12 
coatings on ceria nanoparticles synthesized in-situ using a 
suitable polymer with a higher molecular weight. 
EXAMPLE 6 
Effect of Coating Thickness on Oxidation ofTMB 
Various preparations of coated nanoceria were used to 
perform kinetic studies and assess the effect of the coating 
thickness and nanoparticle size on the catalytic activity of 
nanoceria. Results show that nanoceria's ability to oxidize 
3,3',5,5'-tetramethyl benzidine (TMB) varies with nanopar-
ticle size in the order isPNC (5 nm)>swPNC (12 nm)>isDNC 
(14 nm)>swDNC (100 nm). Interestingly, the nanoparticles 
composed of a thin polyacrylic acid coating have a higher 
catalytic activity than those composed of a thicker dextran 
coating as shown in FIG. 9. This might be attributed to the fact 
that coated nanoceria with a thin and permeable polyacrylic 
acid-coating can facilitate the transfer of molecules in and out 
of the nanoceria core surface faster than a thicker coating. 
Similar experiments were performed with 2,2-azinobis-(3-
ethylbenzothizoline-6-sulfonic acid) (AzBTS) which shows 
similar behavior to TMB. First, with regard to pH values, in 
FIG. lOA, oxidation of AzBTS is pH-dependent with opti-
mum activity at pH 4.0, carried out at room temperature. 
Under the same conditions, small size coated ceria nanopar-
ticles show higher oxidase activity than large size coated ceria 
nanoparticles as shown in FIG. lOB. When measuring absor-
bance at 405 nm, the 5 nm size in-situ synthesized polyacrylic 
acid-coated nanoparticles (isPNC) show the highest oxidase 
activity in nanoceria-promoted oxidation of AzBTS in com-
parison to the 100 nm size step-wise dextran coated nanoceria 
(swDNC). 
EXAMPLE 7 
Effect ofNanoparticle Size on Oxidation ofTMB 
The steady state kinetic parameters for the nanoceria-cata-
lyzed oxidation ofTMB were determined. Typical Michaelis-
Menten curves were obtained for both PNC and DNC. 
Double reciprocal plots of oxidase activity are shown at pH 
4.0 inFIG. llA, at pH 5.0 inFIG. llB, at pH 6.0 inFIG. llC 
and at pH 7.0 in FIG. llD. 
Furthermore, kinetic studies ofnanoceria (isPNC) at vari-
ous pH values indicate faster kinetics at acidic pH (Km 3.8, 
V max 0.7) and much slower kinetics at neutral pH (Km 1.3, 
V maxO.l) as shown in Table 1 below. These results contrast to 
those obtained using the enzyme HRP or iron oxide nanopar-
ticles where slower kinetics are reported even in the presence 
of hydrogen peroxide; see L. Z. Gao et al. Nature Nanotech-
nology 2007 supra 
TABLE 1 
Nanoceria's oxidase kinetics are pH-dependent[a] 
pH Km(mM) vm=(µM/s) 
4.0 3.8 0.70 
5.0 6.9 0.36 
6.0 2.4 0.10 
7.0 1.3 0.10 
[alData obtained with isPNC. 
Double reciprocal plots of oxidase activity for various 
coated nanoceria preparations at pH 4.0 are shown in FIGS. 
12A to 12D. A constant concentration of different coated 
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nanoceria preparations are used with TMB as a substrate. The 
slope of each plot shows that as the hydrodynamic diameter of 
the nanoparticles increases, lower Km and V max values are 
obtained as shown in Table 2 below. 
TABLE2 
Comparison ofnanoceria's size-dependent kinetic parameters[ a] 
14 
additional step to introduce an antibody carrying horseradish 
peroxidase (HRP-antibody) to allow detection. Thus, the 
nanoceria-based method using the polymer coated nanoceria 
particles of the present invention is easier, faster, more eco-
nomical, and provides greater sensitivity. 
EXAMPLE 9 
Coated Nanoceria Conjugated to Folic Acid as 
Nanoceria Size (nm) Km(mM) VmaxCµM/s) 
10 Detection Tool 
is PNC 3.8 0.7 
isDNC 14 
swPNC 12 
swDNC 100 
[a]Data obtained at pH 4.0 
2.1 
1.5 
0.8 
0.6 
0.5 
0.3 
For this purpose, polyacrylic acid coated nanoceria 
(isPNC) was conjugated to folic acid using click chemistry, a 
chemical philosophy introduced by K. Barry Sharpless in 
15 2001, the year he also received the Nobel Prize in Chemistry. 
In FIG. 15, a schematic depiction of the synthesis of a 
folate-conjugated nanoceria particle is shown for the first 
time. Folic acid is the ligand for the folate receptor, which is 
over-expressed in many tumors and cancer cell lines, as 
FIG. 12A shows the steady state kinetic assay of in-situ 
synthesized polyacrylic acid-coated nanoceria (isPNC). FIG. 
12B is a plot of the steady state kinetic of step-wise synthe-
sized PNC (swPNC). FIG. 12C is a plot of the steady state 
kinetic of in-situ synthesized dextran-coated nanoceria (is-
DNC). FIG. 12D is a plot of the steady state kinetic of step-
wise synthesized DNC (swDNC). Similar results were 
observed withAzBTS. 
20 reported by H. Yuan et al. inlraJ. Pharm. 2008, 348, 137 and 
M. E. Nelson et al. in J. Med. Chem. 2004, 47, 3887. 
The fact that the nanoceria preparation with the smaller 
hydrodynamic diameter and thinner coating (isPNC) displays 
the fastest kinetics, contrary to the swDNC, suggests that the 
thickness of the polymer coating plays a key role in the rate of 
oxidation of the substrate. 
FIG. 15 shows the room temperature synthesis of the 
folate-conjugated, coated nanoceria particle 300 wherein 
folic acid is conjugated to polyacrylic acid-coated nanoceria 
25 100 that undergoes triple bond ( alkyne) functionalization 200 
prior to using click chemistry to form a folate-conjugated 
nanoceria particle 300. 
It was hypothesized that a coated nanoceria conjugate with 
folic acid instead of an anti-folate receptor antibody will 
EXAMPLES 
Surface-Modified Ceria Used in Immunoassays 
30 make a more robust nanoprobe for our immunoassay. More-
over, the triple bond ( alkyne) functionalized nanoceria 200 in 
FIG. 15 can facilitate conjugation of an azide derivatized 
folate ligand via click chemistry, offering the opportunity to 
conjugate various ligands such as DNA, peptides, proteins, 
35 aptamers, other small molecules and the like. This provides 
proof that coated nanoceria can be conjugated with a small 
molecule ligand via click chemistry, creating a targetable 
nanocena. 
The oxidase activity of nanoceria in slightly acidic aqueous 
solution makes them potentially useful as aqueous redox 
catalyst and as aqueous oxidants of water pollutants, accord-
ing to B. Meunier, Science 2002, 296, 270. An immediate and 
equally important application of this technology is in the 
design of more robust and reliable TMB-based immunoas- 40 
says using surface-modified or coated cerium oxide nanopai-
ticles. In traditional ELISA, a horseradish peroxidase (HRP) 
labeled secondary antibody is utilized to assess the binding of 
a specific primary antibody to a particular target or surface 
receptor as shown in FIG. 13. This binding event is assessed 45 
by the ability ofHRP to oxidize a chromogenic substrate such 
as TMB in the presence of hydrogen peroxide. In traditional 
ELISA, a high rate of negative results is mainly attributed to 
(1) the instability of the antibodies that when denatured do not 
bind effectively to their target, (2) the instability ofHRP that 50 
when denatured loses its peroxidase activity or (3) the insta-
bility of hydrogen peroxide which upon prolonged storage 
decomposes and losses its ability to oxidize the substrate 
TMB in the presence of HRP. 
It was hypothesized and tested that a coated nanoceria- 55 
based detection approach is more robust than current HRP-
based assays, as no enzyme or hydrogen peroxide would be 
needed for detection as shown in FIG. 14. The oxidase activ-
A fluorescence profile of the folate-conjugated nanoceria 
particles is shown in FIG. 16 wherein a peak for ceria at 410 
nm wavelength and a peak for folate at 450 nm wavelength 
confirm conjugation was successful using click chemistry. 
Experiments were performed using the lung cancer cell 
line (A-549) which over expresses the folate receptor. In 
control experiments, cardiac myocytes (H9c2) that do not 
over express the folate receptor were used. The fact that 
cardiac myocytes (H9c2) do not over express the folate recep-
tor is reported by N. Parker at al. in Anal. Biochem 2005, 338, 
284. 
In a first set of experiments either A-549 or H9c2 cells 
( 6000 cells) were incubated with increasing amount of folate-
cerium oxide nanoparticles in 96-well plate for three hours, 
followed by incubation with TMB (0.04 mM) for 30 minutes 
and monitoring of product formation at 652 nm using a micro-
titer plate reader. As expected, a folate-nanoceria dependent 
binding was observed for the lung carcinoma cell line 
(A-549) compared to cardiac myocytes (H9c2) judged by an 
increase in absorbance at 652 nm with increasing amount of 
folate-nanoceria as shown in FIG. 17. 
In a second set of experiments, an increasing number of 
folate-positive lung carcinoma cells (1500 to 6000 cells) were 
treated with a constant amount of folate-ceria (5.0 µM). 
Results show an increase in TMB oxidation product forma-
tion (652 nm absorbance) with increasing number of A549 
ity of the coated nanoceria, by itself, can facilitate the oxida-
tion and corresponding color development. In FIG. 14, coated 60 
nanoceria is used to directly oxidize 3,3',5,5'-tetramethyl ben-
zidine (TMB) without the use ofHRP or hydrogen peroxide. 
Using this assay, one can perform an immunoassay and iden-
tify the presence and concentration of a target faster and more 
economically. 65 cells as shown in FIG. 18. This was expected as an increasing 
number of A549 translates into an increasing number of sur-
face folate-receptors available for binding to the folate-nano-
Coated nanoceria-based assays outperform the traditional 
sandwich ELISA, which requires hydrogen peroxide and an 
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Thus, when using chromogenic dye substrates oxidation 
occurred at acidic pH values between approximately 1.0 and 
approximately 4.0. When using a chromogenic/fluorescent 
dye substrate, such as amplilfu (amp lex red) and o-phenylene 
diamine (OPD) oxidation of the fluorescent product using 
polymer coated cerium oxide nanoparticles occurred at pH 
ranges between approximately 4.0 and approximately 8.0. 
Ampliflu (10-acetyl-3,7-dihydroxyphenoxazine) is used 
as a sensitive stable substrate for peroxidase detection and is 
ceria. These results demonstrate the utility of cerium oxide 
nanoparticles as a detection tool confirming their dual func-
tionality of binding and detection. Coated nanoceria-based 
assays outperform the traditional sandwich ELISA, which 
requires hydrogen peroxide and an additional step to intro-
duce the antibody carrying horseradish peroxidase (HRP) to 
allow detection. Therefore, the nanoceria-based method is 
easier, faster, more economical, and provides greater sensi-
tivity. 
10 oxidized in the presence of horseradish peroxidase/hydrogen 
peroxide to fluorescent Resorufin. In contrast, nanoceria is 
able to oxidize these substrates to fluorescent products at 
acidic, neutral and moderately alkaline pH values, in the 
Prior to the present invention, a facile, cost effective, non-
toxic step-wise synthesis of biodegradable polymer coated 
nanoceria particles was not available. The synthesis does not 
require surfactants or vigorous experimental conditions and 
the end-product is suitable for unlimited biomedical, diag- 15 
nostic and oxidant applications. 
absence ofH2 0 2 . 
In addition, polymeric cerium oxide nanoparticles are con-
jugated to Protein-G using EDC/NHS carbodiimide chemis-
try. This allowed the conjugation of an antibody to the nano-
ceria in order to perform antibody based cellular ELISA using 
a fluorimetric assay. Since fluorimetric assays tend to be more 
The newly developed step-wise synthesis ofbiodegradable 
polymer coated ceria nanoparticles presented herein is ideal 
for tuning oxidase activity based on the thickness of the 
polymer coating of nanoceria. It was an unexpected finding 
that a slight change in the synthesis procedure would result in 
a wide distribution of particle sizes and coating thickness 
which allow the adjustment of oxidase activity of the coated 
nanocena. 
20 sensitive than chromogenic/colorimetric assays, it is possible 
to detect, using antibody conjugated nanoceria and ampiflu, 
down to 500 cancer cells via cellular ELISA. 
FIGS. 20A to 20D show that the polymer coated cerium 
oxide nanoparticles efficiently oxidize Ampliflu and o-phe-
In FIG. 19A, a schematic representation of in-situ synthe-
sis of polymer coated nanoceria particles shows particles 
formed in an ammonium hydroxide solution over a 24 hour 
period. A ceria nanoparticle that is approximately 3 nm in 
diameter is coated with polyacrylic acid to form a coated 
particle that is Sam in diameter. A ceria nanoparticle that is 
approximately 3 nm in diameter is coated with dextran to 
form a coated particle that is 14 nm in diameter. 
25 nylene diamine at both pH 7.0 and pH 4.0. Vials 1and3 in 
each figure contain a citrate-buffered solution of coated 
cerium oxide nanoparticles with a clear color. In FIG. 20A, 
Ampliflu is added to the clear citrate-buffered solution of 
coated cerium oxide nanoparticles 1, at pH 7 .0, yielding a red 
30 color 2. Also, in FIG. 20A, o-phenylene diamine is added to 
the clear citrate buffered solution of coated cerium oxide 
nanoparticles 3, at pH 7.0, yielding a yellow color 4. 
In FIG. 20B, Ampliflu is added to the clear citrate-buffered 
solution of coated cerium oxide nanoparticles 1, at pH 4.0, 
35 yielding a red color 22. Also, in FIG. 20B, o-phenylene 
diamine is added to the clear citrate buffered solution of 
FIG. 19B shows that when the ceria nanoparticles are 
formed in a step-wise synthesis, ceria nanoparticles are 
formed first and then the polymer is added within minutes and 
allowed to stand for approximately 3 hours to generate larger 
ceria nanoparticles in the core of each coated particle and 
thicker coating on each nanoparticle core. The thickness of 
polymer coating onnanoceria is a direct result of the synthesis 
method. The in-situ synthesis method produces a smaller 40 
nanoceria core and a thin polymer coating; whereas, the step-
wise synthesis method produces a larger nanoceria core and a 
thicker polymer coating. More specifically, in FIG. 19B, step-
wise synthesis produces ceria nanoparticles that are approxi-
mately 7 nm in diameter and with a polyacrylic acid coating 45 
the coated particle measures 12 nm in diameter, whereas, a 
dextran coating of a 7 nm ceria nanoparticle results in a coated 
particle that is approximately 100 nm in diameter. Thickness 
of coating affects utility. 
OxidaseActivity ofCeria Nanoparticles inAcidic to Mod- 50 
erately Alkaline pH 
Oxidase activity of polymer-coated cerium oxide nanopar-
ticles in an acidic pH range from approximately 1.0 to 
approximately 4.0 is demonstrated in the present invention 
wherein test data show the ability of nanoceria to oxidize 55 
various chromogenic/colorimetric dyes such as TMB, 
AzBTS and an organic molecule dopamine. 
It is possible to extend the range of the oxidase activity of 
polymer coated cerium oxide nanoparticles from approxi-
mately 4.0 to a pH value of approximately 8.0. It was a 60 
surprising and unexpected discovery that the oxidase activity 
of nanoceria is dependent not only on the pH but also on the 
nature of the dye substrate utilized. Some substrates upon 
oxidation are converted to a fluorescent product and oxidized 
by nanoceria at both acidic pH and moderately alkaline pH, 65 
such as in a range of from approximately 4.0 to approximately 
8.0. 
coated cerium oxide nanoparticles 3, at pH 4.0, yielding a 
yellow color 44. 
FIGS. 20C and 20D provide visual data on the fluorescent 
properties of the oxidation products obtained on the addition 
of Ampliflu and o-phenylene diamine to clear citrate-buffered 
solutions of coated cerium oxide nanoparticles. In FIG. 20C, 
Ampliflu is added to the clear citrate-buffered solution of 
coated 
cerium oxide nanoparticles 1, at pH 7 .0, and the oxidation 
reaction product under UV light shows bright orange/red 
fluorescent color 2'. Also, in FIG. 20C, o-phenylene diamine 
is added to the clear citrate buffered solution of coated cerium 
oxide nanoparticles 3, at pH 7 .0, yielding an oxidation reac-
tion product which under UV light shows a bright yellow 
fluorescent color 4'. 
In FIG. 20D, Ampliflu is added to the clear citrate-buffered 
solution of coated cerium oxide nanoparticles 1, at pH 4.0, 
and the oxidation reaction product under UV light shows 
bright orange/red fluorescent color 22'. Also, in FIG. 20D, 
o-phenylene diamine (OPD) is added to the clear citrate buff-
ered solution of coated cerium oxide nanoparticles 3, at pH 
4.0, yielding an oxidation reaction product which under UV 
light shows a bright yellow fluorescent color 44'. 
Collectively, FIGS. 20A-20D confirm that nanoceria medi-
ated oxidized product of Ampliflu and o-phenylene diamine 
(OPD) can be used both as colorimetric and fluorimetric 
substrates especially in ELISA. These oxidations reaction 
have been carried out in pH range 4.0 to 8.0. 
Advantages of using Ampliflu as peroxidase substrate in 
ELISA is because its fluorescent product has excitation/emis-
sion maxima of 570/585, in this range there is much less 
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interference from the auto fluorescence of most biological 
samples. This property makes Ampliflu a suitable reagent for 
various immunoassays and cellular ELISA. In addition, by 
using fluorescence one could get a more sensitive assay. 
The ultraviolet (UV) profile of oxidized product of 
Ampliflu is shown in FIG. 21A wherein the absorbance maxi-
mum is at 565 nm and the absorbance maximum for o-phe-
nylene diamine is shown at 417 nm in FIG. 21C. 
The fluorescence spectrum for oxidizedAmpliflu shows an 
emission peak at 585 nm in FIG. 21B and an emission peak at 
570 nm is shown for oxidized o-phenylene diamine in FIG. 
21D. Together, FIGS. 21A and 21C establish identifying pro-
files foroxidized product ofAmpliflu and FIGS. 21B and 21D 
provide identifying data for oxidized product of o-phenylene 
diamine (OPD). 
FIG. 22 is a schematic representation of the conjugation of 
Protein-G on polyacrylic acid coated cerium oxide nanopar-
ticles. Polyacrylic acid coated nanoceria is successfully func-
tionalized with protein-G using carbodiimide chemistry. Pro-
tein-G introduces versatility in the system since protein-G 
can be used to immobilize various antibodies. A similar result 
is obtainable using Protein-A. This technique allowed us to 
conjugate various antibody such as antifolatc-receptor anti-
body, EpiCam antibody and the like, depending upon the 
target. 
In FIG. 23 the surface conjugation of protein-G on poly-
acrylic acid coated nanoceria was confirmed by measurement 
of zeta potential, which shows a shift in zeta potential value 
from -75.3 for nanoceria to -35.1 mV for conjugated nano-
cena. 
18 
FIG. 27A and FIG. 27B provide a graphic view of the 
disadvantages of using a colorimetric substrate, such as TMB, 
in the nanoceria mediated detection ofEpi-CAM in MCF-7 
cells. 
In FIG. 27A, at ph 7.0 and with chromogenic cellular 
ELISA using TMB (a colorimetric substrate) it was not pos-
sible to obtain enough signal intensity to detect the Epi-CAM 
expression MCF-7 cells. This is due to the fact that nanoceria 
cannot oxidize at pH 7 the colorimetric dye TMB. In FIG. 
10 27B, at pH 4.0 using cellular ELISA and colorimetric sub-
strate TMB, the colorimetric cellular ELISA with TMB has 
detection limit up to 3600 cells employing nanoceria-protein-
G-epicam antibody conjugate. Thus, at pH 4, nanoceria can 
indeed oxidize the colorimetric substrate (TMB) and achieve 
15 detection ofEpi-CAM expressing cells, although not as good 
as with a fluorescent dye (such as ampiflu or OPD). 
An additional advantage of using Ampliflu is in cyclic 
oxidation of Ampliflu using nanoceria as measured by XPS. 
The data confirms that nanoceria indeed possesses an enzy-
20 matic auto regenerative behavior toward the oxidation of 
Ampiflu resulting in a sensitivity and detection limit that can 
be regenerated rather than continued replacement of reagents. 
FIGS. 28A and 28B are schematic representations that 
compare the mediated oxidation of Ampliflu by nanoceria 
25 and traditional HRP/H20 2 . In FIG. 28A, at pH 4.0 or pH 7.0, 
a robust nanoceria particle system, without hydrogen perox-
ide, provides only one final, stable fluorescent oxidation 
product. In FIG. 28B, at pH 4.0 and pH 7.0, HRP/H20 2 
mediated oxidation is labile to concentration of HRP, H2 0 2 
30 and experimental conditions, resulting in non-fluorescent 
oxidation product, which may hamper the ELISA. Thus, it 
has been determined that the nanoceria mediated oxidation of 
Ampliflu is preferable to HRP/H2 0 2 mediated oxidation of 
FIG. 24A is a schematic drawing of nanoceria-Protein-G 
antibody based cellular ELISA with Ampliflu substrate 5 
wherein a single nanoparticle conjugate 10 is employed to 
monitor the expression of surface cell receptor 15 by chang- 35 
ing the antibody on nanoparticle conjugate 10 to the oxidized 
version 20. In FIG. 24B, a traditional cell based ELISA shows 
the use of Ampliflu substrate 6 with hydrogen peroxide 8 and 
horseradish peroxidase antibody 12 to monitor the expression 
Ampliflu. 
In Table I below, the advantages of nanoceria based oxida-
tion of peroxidase substrate and cellular ELISA are summa-
rized, and are not a limitation to the invention. 
of surface cell receptor 16 by changing the antibody on horse-
radish peroxidase 12 to the oxidized version 24. The advan-
tage of the process in FIG. 24A over the traditional process in 
FIG. 24B is that the toxic hydrogen peroxide component can 
be omitted. 
FIG. 25A is a graph showing nanoceria-protein-G-anti-
folate receptor antibody conjugate used to monitor the 
expression of folate receptor on folate positive lung carci-
noma cell line (A-549 cells). 
As a control, FIG. 25B is a graph showing that it was not 
possible to monitor the expression of folate receptor in 
MCF-7 breast carcinoma cell lines which do not express the 
folate receptor. As shown by the graph in FIG. 25B, no sig-
nificant signal intensity was found with MCF-7 cell lines. 
FIG. 26A is a graph showing the expression ofEpi-CAM 
40 
45 
50 
55 on MCF-7 cell lines using a nanoceria-Protein-G-antiEpi-
CAM antibody-conjugate. FIG. 26B is a graph showing the 
expression of the Epi-CAM on MCF-7 cell lines using the 
traditional HRP/H20 2 system. A comparison of the graphs 
reveals that in FIG. 26A the nanoceria conjugate provides a 
better cell density curve and gives better signal intensity 60 
differences based on the number of cells being screened. In 
FIG. 26B, when screening the same number of cells, due to 
saturation, the HRP/H20 2 system can not provide a clear 
distinction or signal intensity based at different numbers of 
cells or saturation levels. Thus, the nanoceria conjugate of the 65 
present invention provides greater sensitivity when screening 
for presence of cancer cells using fluorimetric methods. 
Advantages ofNanoceria's Oxidase like behavior 
Reagents Abs* Ent* Advantages 
Arnpliflu 570 585 Fast fluorescence and color development 
Gives stable fluorescent product resorufin 
Single reagent based and more sensitive 
Independent ofHRP/H20 2 
o-phenylene 417 570 Fast fluorescence and color development 
di amine Gives stable fluorescent product 
(OPD) Independent ofHRP/H20 2 
Single reagent based 
TMB[ReJl 652 NA Readily oxidize and fast color development 
Better kinetic compare to HRP/H2 0 2 
Independent ofHRP/H20 2 
Single reagent based 
AzBTS[ReJl 405 NA Fast color development 
Better kinetic compare to HRP/H2 0 2 
Independent ofHRP/H20 2 
Single reagent based 
*Absorbance (Abs) and Emission (Em) maxima in run. 
NA= not applicable 
Prior to the present invention, it was not known that coated 
nanoceria is useful as an aqueous redox catalyst, an aqueous 
oxidizing agent or oxidase with enhanced activity at pH val-
ues between approximately 1 and approximately 8. 
Prior to the present invention, it was not known that coated 
nanoceria is useful in the decomposition, decontamination or 
inactivation by oxidation of organic contaminants, or pesti-
cides, nerve agents and chemical warfare agents, at acidic pH 
values between approximately 1 and approximately 8. 
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Prior to the present invention, it was not known that coated 
nanoceria is useful as a targetable nanocatalyst, by conjuga-
tion or attachment of various targeting ligands to the coating 
on the nanoparticle; it was also not known that a targetable 
coated nanoceria is useful as a colorimetric probe in immu-
noassays, such as ELISA, and other molecule binding assays 
that involve the use of a molecule in solution that upon oxi-
dation change the color of the solution. 
Prior to the present invention, it was not known that a 
targetable coated nanoceria is useful as a colorimetric probe 10 
in histology, where the localization of nanoceria to a particu-
lar organ or tissue is assessed by treatment with 3,3',5,5'-
tetramethyl benzidine (TMB) or any other oxidation sensitive 
dye. 
20 
5. The polymer coated cerium oxide nanoparticles of claim 
4, wherein the carboxylated polymer is polyacrylic acid. 
6. The polymer coated cerium oxide nanoparticles of claim 
5, wherein the polysaccharide is dextran. 
7. The polymer coated cerium oxide nanoparticles of claim 
4, wherein the carbohydrate polymer is a polysaccharide. 
8. The polymer coated cerium oxide nanoparticles of claim 
4, wherein the carbohydrate polymer is reduced dextran, car-
boxyl methyl reduced dextran, arabinogalactan, or chitosan. 
9. The polymer coated cerium oxide nanoparticles of claim 
1, wherein the polymer coated cerium oxide nanoparticles 
exhibit oxidant property in an acidic condition with pH 
between approximately 1 and approximately 4. 
10. The polymer coated cerium oxide nanoparticles of 
15 claim 1, wherein the polymer coated cerium oxide nanopar-
ticles are polyacrylic acid-coated cerium oxide nanoparticles 
having the average hydrodynamic diameter approximately 12 
nm. 
In conclusion, we report that coated nanoceria possess 
unique oxidase activity as it can facilitate the fast oxidation of 
organic dyes and small molecules in acidic to moderately 
alkaline conditions measured ina range from pH 1.0 to pH 8.0 
without the need of hydrogen peroxide. When compared to 
other systems that require peroxides or proteins (such as 20 
oxidases and peroxidases ), coated nanoceria of the present 
invention is a more robust and economical water-soluble 
redox nanocatalyst, as it is not susceptible to denaturation or 
decomposition. Furthermore, conjugation with targeting 
ligands makes coated nanoceria an effective nanocatalyst and 
detection tool in immunoassays. Taken together, these results 
demonstrate that this unique aqueous oxidase activity of 
coated nanoceria can be used in a wide range of new potential 
applications in biotechnology, environmental chemistry and 
medicine. 
11. The polymer coated cerium oxide nanoparticles of 
claim 1, wherein the polymer coated cerium oxide nanopar-
ticles are dextran-coated cerium oxide nanoparticles having 
the average hydrodynamic diameter approximately 100 nm. 
12. The polymer coated cerium oxide nanoparticles of 
claim 1, wherein the polymer coated cerium oxide nanopar-
25 ticles further comprise a ligand conjugated to the polymer 
coating. 
30 
While the invention has been described, disclosed, illus-
trated and shown in various terms of certain embodiments or 
modifications which it has presumed in practice, the scope of 
the invention is not intended to be, nor should it be deemed to 
be, limited thereby and such other modifications or embodi- 35 
ments as may be suggested by the teachings herein are par-
ticularly reserved especially as they fall within the breadth 
and scope of the claims here appended. 
13. The polymer coated cerium oxide nanoparticles of 
claim 12, wherein the ligand is folic acid and the polymer 
coated cerium oxide nanoparticles are folate-conjugated. 
14. The polymer coated cerium oxide nanoparticles of 
claim 12, wherein the polymer coated cerium oxide nanopar-
ticles having a conjugated ligand bind specifically to a target 
of an immunoassay and also oxidize a dye for detection in the 
immunoassay. 
15. The polymer coated cerium oxide nanoparticles of 
claim 1, wherein the polymer coated cerium oxide nanopar-
ticles further comprise an antibody conjugated to the polymer 
coating. 
16. The polymer coated cerium oxide nanoparticles of 
We claim: 
1. Polymer coated cerium oxide nanoparticles, each com-
prising a cerium oxide core with an average hydrodynamic 
diameter of approximately 7 nm, and a polymer coating with 
40 claim 15, wherein the polymer coated cerium oxide nanopar-
ticles having a conjugated antibody enable detection of a 
target in a horseradish peroxidase based immunoassay in the 
absence of the horseradish peroxidase and hydrogen perox-
ide. a thickness to an extent such that said polymer coated cerium 
oxide nanoparticles have an average hydrodynamic diameter 45 
in a range from approximately 12 nm to approximately 100 
nm, wherein oxidant property of the polymer coated cerium 
oxide nanoparticles varies with the thickness of the polymer 
coating of the polymer coated cerium oxide nanoparticles, 
and is pH dependent. 
17. The polymer coated cerium oxide nanoparticles of 
claim 1, wherein the polymer coated cerium oxide nanopar-
ticles are a redox catalyst with an enhanced activity at an 
acidic pH between approximately 1 and approximately 4. 
18. The polymer coated cerium oxide nanoparticles of 
2. The polymer coated cerium oxide nanoparticles of claim 
1, wherein the oxidant property of the polymer coated cerium 
oxide nanoparticles decreases with an increase in the thick-
ness of the polymer coating of the polymer coated cerium 
oxide nanoparticles. 
50 claim 1, wherein the polymer coated cerium oxide nanopar-
ticles are an oxidizing agent in decomposition, decontamina-
tion and inactivation of organic contaminants, pesticides, 
nerve agents or chemical warfare agents at an acidic pH 
55 
3. The polymer coated cerium oxide nanoparticles of claim 
1, wherein said polymer coated cerium oxide nanoparticles 
are formed by mixing a biocompatible polymer with an aque-
ous reaction mixture of a cerium salt and anmionium hydrox-
ide after an initial formation of cerium oxide nanoparticles in 60 
the reaction mixture, thereby obtaining said average hydro-
dynamic diameters of the cerium oxide core and the polymer 
coated nanoparticles. 
4. The polymer coated cerium oxide nanoparticles of claim 
1, wherein the biocompatible polymer is at least one selected 65 
from the group consisting of carbohydrate polymer, synthetic 
polyol, carboxylated polymer, and derivatives thereof. 
between approximately 1 and approximately 4. 
19. The polymer coated cerium oxide nanoparticles of 
claim 1, wherein at an acidic pH between approximately 1 
and approximately 4 the biocompatible polymer coated 
cerium oxide nanoparticles are an oxidant to chromogenic 
dyes, fluorescent dyes, and photoluminescent dyes used for 
peroxidase or oxidase detection, and enable to oxidize the 
dyes to cause a color change. 
20. The polymer coated cerium oxide nanoparticles of 
claim 19, wherein said dyes comprise 3,3',5,5'-tetramethyl 
benzidine (TMB) or 2,2-azinobis-(3-ethylbenzothizoline-6-
sulfonic acid) (AzBTS). 
21. A reagent for use in biochemical analysis and detection 
comprising a plurality of polymer coated cerium oxide nano-
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particles, each thereof comprising a cerium oxide core with 
an average hydrodynamic diameter of approximately 7 nm, 
and a polymer coating with a thickness to an extent such that 
said polymer coated cerium oxide nanoparticles have an aver-
age hydrodynamic diameter in a range from approximately 
12 nm to approximately 100 nm, wherein oxidant property of 
the polymer coated cerium oxide nanoparticles varies with 
the thickness of the polymer coating of the polymer coated 
cerium oxide nanoparticles, and is pH dependent. 
22. The diagnostic device reagent of claim 21, wherein the 10 
oxidant property of the polymer coated cerium oxide nano-
particles decreases with an increase in the thickness of the 
polymer coating of the polymer coated cerium oxide nano-
particles. 15 
23. The reagent of claim 21, wherein said polymer coated 
cerium oxide nanoparticles are formed by mixing a biocom-
patible polymer with an aqueous reaction mixture of a cerium 
salt and ammonium hydroxide after an initial formation of 
cerium oxide nanoparticles in the reaction mixture, thereby 20 
obtaining said average hydrodynamic diameters of the cerium 
oxide core and the polymer coated nanoparticles. 
24. The reagent of claim 21, wherein the biocompatible 
polymer is at least one selected from the group consisting of 
carbohydrate polymer, synthetic polyol, carboxylated poly- 25 
mer, and derivatives thereof. 
25. The reagent of claim 24, wherein the carboxylated 
polymer is polyacrylic acid. 
26. The reagent of claim 24, wherein the carbohydrate 
polymer is a polysaccharide. 
27. The reagent of claim 26, wherein the polysaccharide is 
dextran. 
28. The reagent of claim 24, wherein the carbohydrate 
polymer is reduced dextran, carboxyl methyl reduced dext-
ran, arabinogalactan, or chitosan. 
29. The reagent of claim 21, wherein the polymer coated 
cerium oxide nanoparticles are polyacrylic acid-coated 
30 
35 
22 
cerium oxide nanoparticles having the average hydrodynamic 
diameter approximately 12 nm. 
30. The reagent of claim 21, wherein the polymer coated 
cerium oxide nanoparticles are dextran-coated cerium oxide 
nanoparticles having the average hydrodynamic diameter 
approximately 100 nm. 
31. The reagent of claim 21, wherein the polymer coated 
cerium oxide nanoparticles further comprise a ligand conju-
gated to the polymer coating. 
32. The reagent of claim 31, wherein the polymer coated 
cerium oxide nanoparticles having a conjugated ligand bind 
specifically to a target of an immunoassay and also oxidize a 
dye for detection in the immunoassay. 
33. Thereagent of claim 21, wherein the ligand is folic acid 
and the polymer coated cerium oxide nanoparticles are folate-
conjugated. 
34. The reagent of claim 21, wherein folate-conjugated 
polymer coated cerium oxide nanoparticles are specific to 
folate receptors of cells. 
35. The reagent of claim 21, wherein the polymer coated 
cerium oxide nanoparticles further comprise an antibody con-
jugated to the polymer coating. 
36. The reagent of claim 35, wherein the polymer coated 
cerium oxide nanoparticles having a conjugated antibody 
enable detection of a target in a horseradish peroxidase based 
immunoassay in the absence of the horseradish peroxidase 
and hydrogen peroxide. 
37. The reagent of claim 21, wherein at an acidic pH 
between approximately 1 and approximately 4 the biocom-
patible polymer coated cerium oxide nanoparticles are an 
oxidant to chromogenic dyes, fluorescent dyes, and photolu-
minescent dyes used for peroxidase or oxidase detection, and 
enable to oxidize the dyes to cause a color change. 
38. The reagent of claim 37, wherein said dyes comprise 
3,3',5,5'-tetramethyl benzidine (TMB) or 2,2-azinobis-(3-
ethylbenzothizoline-6-sulfonic acid) (AzBTS). 
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